Avadel Pharmaceuticals plc (NASDAQ: AVDL)
$11.3100
+0.5600 ( +5.31% ) 449.4K
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
Market Data
Open
$11.3100
Previous close
$10.7500
Volume
449.4K
Market cap
$1.06B
Day range
$10.6780 - $11.5600
52 week range
$10.4100 - $19.0900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Jun 18, 2024 |
3 | Insider transactions | 2 | May 21, 2024 |
8-k | 8K-related | 15 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
10-q | Quarterly Reports | 68 | May 08, 2024 |
8-k | 8K-related | 15 | May 08, 2024 |
8-k | 8K-related | 14 | May 08, 2024 |
3 | Insider transactions | 2 | May 03, 2024 |
10-k/a | Quarterly Reports | 13 | Apr 26, 2024 |
8-k | 8K-related | 13 | Apr 15, 2024 |